SchoolDataLists is the leading provider of quality school mailing and email lists.They have verified the names, contact information, and email addresses of all the schools.Up-to-date email addresses are the foundation of a dependable school contact list.The database help marketers reach their intended audience, whether it is administrators for school-wide purchasing or individual teachers who want to boost the ability of students in their classrooms.An email is optimum when it comes to marketing.Education marketers have always been looking to connect with school decision-makers.SchoolDataLists is providing an accurate email database for customers to build targeted sales and marketing campaigns.Database of Schools hold a record of 472,467-School mailing list32,462-Catholic schools email list192,167-Principals email list21,620-Superintendents email list832,465-Teacher mailing list72,368-Charter school email list679,632-College and Universities email list81,740-Community school mailing list72,735-Private school mailing list7,620-Dental College email list81,672-Daycare email list53,760-Elementary schools contact list9,536-Art and craft schools list116,732-Boarding school mailing list37,835-High schools email list41,236-Homeschooling mailing list92,620-Kindergarten mailing list92,586-Magnet school mailing list18,736-Medical college mailing list18,532-Middle schools email list32,876-Music schools mailing list96,382-Nursing college email list37,286-Physical education mailing list162,487-Preschool mailing list38,274-Beauty schools mailing list62,586-Vocational school mailing list16,582-Speech-language therapist list91,784-Technical college mailing list133,529-UK Schools Database32,467-International Schools Email List1,917-Art Instruction Schools Email Database3,520-Christian Schools Email Database2,634-Community College Email List92,620- k-12 database961-Special Education Compliance Coordinator Email Lists1,062-Cosmetology School Email List1,067-Foreign Language Teachers List1,463-Law School Email List1,132-Lutheran School Email Address1,467-Medical Colleges Email List16,532-Public School Mailing List1,054-Director of Curriculum Instruction and Assessment1,076-Elementary Foreign/World Language Director Database4,617-High School Coaches Email List5,372-Pennsylvania Superintendent Lists9,874-Coaches Email Lists17,754-School District Database1,638-Book Publishing Companies Database5,178-Special Education Schools Data Buy Database of Schools to build support and collect information of the schools in the US.Marketers will be able to reach message boards and emails of teachers, principals, and other administrators.SchoolDataLists provide a secured process of data acquisition as we know about the security protocols and issues.They also provide different industry-specific mailing database of schools.Marketers can access to best quality schools' email addresses that are vital for successful marketing.
Manu Kumar Jain, Managing Director and Global Vice President of Xiaomi India, unveiled the new Xiaomi Mi Notebook 14 IC on his Twitter page. Last ... The post Xiaomi Mi Notebook 14 IC is officially launched appeared first on Gizchina.com.
5
Still the most popular, Bitcoin is the cryptocurrency that began every one of it.It is currently the greatest industry limit at around $41 million and 's been around for the past 8 years.Equally as a payment system and as a stored price, Bitcoin allows users to easily obtain and deliver bitcoins.The idea of the blockchain is the foundation in which Bitcoin is based.It is required to comprehend the blockchain principle to get a feeling of what the cryptocurrencies are typical about.To put it really, blockchain is a repository distribution that shops every network transaction as a data-chunk named a "block."Each consumer has blockchain copies when Alice sends 1 bitcoin to Mark, every individual on the system understands it.One option to Bitcoin, Litecoin attempts to solve most of the problems that maintain Bitcoin down.
Looking for Hernia Specialist doctor or surgeon? Dr. Chirag Thakkar is a gastro-intestinal, advanced laparoscopic and obesity surgeon. He is specialized in GERD and Hernia treatment, heartburn treatment, Acid reflux treatment in Ahmedabad, Gujarat. He is the founder director of Adroit Centre for Digestive and Obesity Surgery. Dr. Chirag did his M.B.B.S. Medical College, Ahmedabad, followed by his General Surgical training (M. S. in General Surgery) at Smt.
Biden's team expected the US COVID-19 death toll to climb sharply, Dr. Rochelle Walensky said, but was "confident" it would meet its vaccine target.
8
Brody Buhler (left), global managing director, post and parcel industry group, Accenture, talks to PPTI about the company’s latest research and the impact artificial intelligence services will have on the postal sector.This is the 10th Achieving High Performance in the Post and Parcel Industry report Accenture has researched and published, what’s different about this one?Our methodology has changed.The market is pricing stock with the assumption that posts will have less turnover than they have today and that’s scary.I think the market analysts struggle with these companies, and the organizations themselves often don’t understand the right levers to pull in the market.It also shows that parcels are the growth engine.But what is problematic is the highly competitive environment around the last mile.There are the incumbents and the large retailers doing their own deliveries and then disruptive startups in the last mile.The startups are almost always asset-light and data-rich.That battleground is tough and posts are going to have to adapt and do the last mile in very different ways in the future.How do you think last-mile deliveries will change?There’s a combination of trends in the market.
Plumbing Services MelbourneCJM Plumbing Melbourne are a young but highly experienced team of qualified and trustworthy trades people serving metropolitan Melbourne in the commercial plumbing, domestic plumbing, drainage, and civil construction industry.Founded in 2015, Director, Chris McDonald, decided to pursue his passion for plumbing.After managing a leading civil plumbing company for 4 years, he decided it was time to go out on his own.Based in Melbourne’s Fitzroy, CJM Plumbing Melbourne are central to serve Metropolitan Melbourne for all your plumbing and civil needs.At CJM Plumbing services Melbourne we pride ourselves on Safety and Quality!Why choose us!CJM Plumbing Repairs Melbourne are a fully ISO accredited company across the 3 major water utility organizations servicing Melbourne metropolitan areas.We have been serving our clients; residents, businesses and government with utmost priority and respect.We guarantee superior work quality and service to all our clients.We provide a 24-hour emergency service and repair service that is unmatched in the industry.If you ever need a last minute-urgent fix, we’re here for you.
Exam4help.com has appeared as the most significant source of help for IT candidates.You can download 500-325 Practice Questions from this site and learn about all the field corners.Our experts in the field are taking charge of this preparatory process, which is so short and sure.Only those concepts are included in Collaboration Servers and Appliances Role Exam questions and answers considered ingredients of the basic concepts.There is a squad of teachers who will lead you in the right way.Now is the time to take a free demo version of this short director.
Appeal to a wider audience by making marketing more accessible and inclusive, details Tylor Loposser, Art Director at Emma, a CM Group company. The post Design for inclusion: Embrace accessibility-based design appeared first on ClickZ.
5
Roof & Valance Fully Printed With Unlimited Colors & Graphics.3 Full Walls Single Side Fully Printed with Unlimited colors & Graphics.Dye Sublimation Printing On A 600D Polyester.Fire retardant, Water Resistant And UV Coated..Deluxe - 40mm Hexagonal Aluminium Frame.Director Chair with 10X10 Canopy Tent.(4) Velcro loop added to inside of Valance edge (Easy to connect full walls).2 Years Warranty  Features and BenefitsRoof & Valance Fully Printed With Unlimited Colors & GraphicsDye Sublimation Printing On A 600D PolyesterFire retardant, Water Resistant And UV Coated.Deluxe - 40mm Hexagonal Aluminium Frame (Rust Proof)(4) Velcro loop added to inside of Valance edge (Easy to connect full walls)(1) Premium Heavy Duty Carrying Case with Wheels (1000D Oxford)(4) Pieces of Extra Strength Double Sandbags(4) Pieces Steel Ground Stakes & Ropes2 Years WarrantyAvailable Sizes10 X 10 Canopy tent Package10X15 Canopy tent Package10X20 Canopy tent Package 20X20Canopy tent Package                        Contact Us                Branded Canopy Tents                San Francisco Office                 1390 Market Street,Suite 200                San Francisco 94102 USA                [email protected]               Google Map URL: https://bit.ly/3gu2Bz9                            
 Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages Roots Analysis is pleased to announce the publication of its recent study, titled,  “Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030.”  The report features an extensive study on the contract service providers within the biopharmaceutical industry.The study features in-depth analysis, highlighting the capabilities of a diverse set of biopharmaceutical CMOs and CDMOs.Amongst other elements, the report includes:A detailed review of the overall landscape of the biopharmaceutical contract manufacturing market, featuring a comprehensive list of active CMOs and detailed analysis of the manufacturing service providers based on a number of parameters.Elaborate profiles of key players that have a diverse range of capabilities for the development, manufacturing, and packaging of biologics.A detailed discussion on the key enablers in this domain, including certain niche product classes, which are likely to have a significant impact on the growth of the contract services market.A case study on the growing global biosimilars market, highlighting the opportunities for biopharmaceutical CMOs and CDMOs.A case study comparing the key characteristics of large molecule and small molecule drugs, along with details on the various steps involved in their respective manufacturing processes.A discussion on challenges related to in-house manufacturing, featuring a brief overview of the various parameters that a drug / therapy developer may need to take into consideration while deciding whether to manufacture its products in-house or outsource.An analysis of the recent collaborations (signed since 2013) focused on the contract manufacturing of biologics.A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2013-2018, along with the geographical distribution of this activity.An in-depth analysis of more than 490 grants that have been awarded to research institutes engaged in next generation immune checkpoint therapy-related projects.An analysis on the recent trends within biopharmaceutical contract manufacturing industry, highlighting various facility and capability expansions.A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders.A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders.A discussion on affiliated trends, key drivers, and challenges, under a comprehensive SWOT framework.A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing CMO services to medical device developers.A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)Commonly Outsourced Business OperationsActive Pharmaceutical Ingredients (API)Finished Dosage Formulations (FDF)Types of Expression SystemMammalianMicrobialOthersCompany SizeSmallMid-SizedLarge and Very LargeScale of OperationPreclinicalClinicalCommercialKey Geographical Region North AmericaEuropeAsia-PacificRest of the World  The report also features detailed transcripts of discussions held with the following experts:Astrid Brammer, Senior Manager Business Development, Richter-Helm Mathias Schmidt (Chief Executive Officer, ArmaGen)Birgit Schwab, Senior Manager Strategic Marketing, Rentschler BiotechnologieChristian Bailly, Director of CDMO, Pierre FabreClaire Otjes, Assistant Marketing Manager, Batavia BiosciencesDavid C Cunningham, Director Corporate Development, Goodwin BiotechnologyDietmar Katinger, Chief Executive Officer, Polymun ScientificDenis Angioletti, Chief Commercial Officer, Cerbios-PharmaJeffrey Hung, Chief Commercial Officer, Vigene BiosciencesKevin Daley, Director Pharmaceuticals, NovasepMark Wright, Site Head, Grangemouth, Piramal HealthcareNicolas Grandchamp, R Leader, GEG TechRaquel Fortunato, Chief Executive Officer, GenIbet BiopharmaceuticalsSebastian Schuck, Head of Business Development, Wacker BiotechStephen Taylor, Senior Vice President Commercial, FUJIFILM Diosynth BiotechnologiesTatjana Buchholz, Marketing Manager, PlasmidFactory and Marco Schmeer, Project Manager, PlasmidFactoryTim Oldham, Chief Executive Officer, Cell Therapies Key companies covered in the report3P BiopharmaceuticalsAbzenaAlbany Molecular ResearchBioVectraBioXcellence (Boehringer Ingelheim)CelonicCharles River LaboratoriesChemPartnerCobra BiologicsCordenPharmaCytovance BiologicsGE HealthcareGoodwin BiotechnologyGrand River Aseptic ManufacturingIDT BiologikaKBI BioPharmaKemwell BiopharmaLFB BiomanufacturingMeridian Life SciencePatheonPfizer CentreOnePX'TherapeuticsSamsung BioLogicsSanofi, CEPiAThermo Fisher ScientificVetter Pharma International For more information please click on the following link:Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030 Other Recent OfferingsCell Therapy Manufacturing Market (3rd Edition), 2019-2030Antibody Contract Manufacturing Market, 2020-2030China Biopharmaceutical Contract Manufacturing Market, 2020-2030Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030 About Roots AnalysisRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry.The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.If you’d like help with your growing business needs, get in touch at [email protected] Contact InformationRoots Analysis Private LimitedGaurav Chaudhary+1 (415) 800 [email protected]
COVAXIN is India’s ‘first’ indigenous COVID-19 antibody, created by Hyderabad-based Bharat Biotech in a joint effort with ICMR and NIV.Indian specialists have given the green light to test Bharat Biotech’s COVID-19 antibody in Phase I and Phase II clinical preliminaries.India’s first potential COVID-19 antibody has been given endorsement for Phase I and Phase II clinical preliminaries.Named COVAXIN™, the immunization was created by Bharat Biotech and has been allowed endorsement from the Drugs Controller General of India (DCGI).Human clinical preliminaries are booked to begin across India in July 2020Bharat Biotech made COVAXIN in a joint effort with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).As indicated by the organization, the SARS-CoV-2 strain was confined in NIV, Pune and moved to Bharat Biotech.The indigenous, inactivated immunization was created and made in Bharat Biotech’s office situated in Hyderabad, India.The DCGI conceded consent to start Phase I and II human clinical preliminaries after the organization submitted results created from pre-clinical investigations, illustrating “promising” and “broad” security and safe reactions.Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech, stated: “We are pleased to declare COVAXIN, India’s first indigenous immunization against COVID-19.The coordinated effort with ICMR and NIV was instrumental in the improvement of this immunization.The proactive help and direction from CDSCO has empowered endorsements to this task.
Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages Roots Analysis is pleased to announce the publication of its recent study, titled,  “Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030.”  The report features an extensive study on the contract service providers within the biopharmaceutical industry.The study features in-depth analysis, highlighting the capabilities of a diverse set of biopharmaceutical CMOs and CDMOs.Amongst other elements, the report includes:A detailed review of the overall landscape of the biopharmaceutical contract manufacturing market, featuring a comprehensive list of active CMOs and detailed analysis of the manufacturing service providers based on a number of parameters.Elaborate profiles of key players that have a diverse range of capabilities for the development, manufacturing, and packaging of biologics.A detailed discussion on the key enablers in this domain, including certain niche product classes, which are likely to have a significant impact on the growth of the contract services market.A case study on the growing global biosimilars market, highlighting the opportunities for biopharmaceutical CMOs and CDMOs.A case study comparing the key characteristics of large molecule and small molecule drugs, along with details on the various steps involved in their respective manufacturing processes.A discussion on challenges related to in-house manufacturing, featuring a brief overview of the various parameters that a drug / therapy developer may need to take into consideration while deciding whether to manufacture its products in-house or outsource.An analysis of the recent collaborations (signed since 2013) focused on the contract manufacturing of biologics.A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2013-2018, along with the geographical distribution of this activity.An in-depth analysis of more than 490 grants that have been awarded to research institutes engaged in next generation immune checkpoint therapy-related projects.An analysis on the recent trends within biopharmaceutical contract manufacturing industry, highlighting various facility and capability expansions.A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders.A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders.A discussion on affiliated trends, key drivers, and challenges, under a comprehensive SWOT framework.A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing CMO services to medical device developers.A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)Commonly Outsourced Business OperationsActive Pharmaceutical Ingredients (API)Finished Dosage Formulations (FDF)Types of Expression SystemMammalianMicrobialOthersCompany SizeSmallMid-SizedLarge and Very LargeScale of OperationPreclinicalClinicalCommercialKey Geographical Region North AmericaEuropeAsia-PacificRest of the World  The report also features detailed transcripts of discussions held with the following experts:Astrid Brammer, Senior Manager Business Development, Richter-Helm Mathias Schmidt (Chief Executive Officer, ArmaGen)Birgit Schwab, Senior Manager Strategic Marketing, Rentschler BiotechnologieChristian Bailly, Director of CDMO, Pierre FabreClaire Otjes, Assistant Marketing Manager, Batavia BiosciencesDavid C Cunningham, Director Corporate Development, Goodwin BiotechnologyDietmar Katinger, Chief Executive Officer, Polymun ScientificDenis Angioletti, Chief Commercial Officer, Cerbios-PharmaJeffrey Hung, Chief Commercial Officer, Vigene BiosciencesKevin Daley, Director Pharmaceuticals, NovasepMark Wright, Site Head, Grangemouth, Piramal HealthcareNicolas Grandchamp, R Leader, GEG TechRaquel Fortunato, Chief Executive Officer, GenIbet BiopharmaceuticalsSebastian Schuck, Head of Business Development, Wacker BiotechStephen Taylor, Senior Vice President Commercial, FUJIFILM Diosynth BiotechnologiesTatjana Buchholz, Marketing Manager, PlasmidFactory and Marco Schmeer, Project Manager, PlasmidFactoryTim Oldham, Chief Executive Officer, Cell Therapies Key companies covered in the report3P BiopharmaceuticalsAbzenaAlbany Molecular ResearchBioVectraBioXcellence (Boehringer Ingelheim)CelonicCharles River LaboratoriesChemPartnerCobra BiologicsCordenPharmaCytovance BiologicsGE HealthcareGoodwin BiotechnologyGrand River Aseptic ManufacturingIDT BiologikaKBI BioPharmaKemwell BiopharmaLFB BiomanufacturingMeridian Life SciencePatheonPfizer CentreOnePX'TherapeuticsSamsung BioLogicsSanofi, CEPiAThermo Fisher ScientificVetter Pharma International For more information please click on the following link:Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030 Other Recent OfferingsCell Therapy Manufacturing Market (3rd Edition), 2019-2030Antibody Contract Manufacturing Market, 2020-2030China Biopharmaceutical Contract Manufacturing Market, 2020-2030Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030 About Roots AnalysisRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry.The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.If you’d like help with your growing business needs, get in touch at [email protected] Contact InformationRoots Analysis Private LimitedGaurav Chaudhary+1 (415) 800 [email protected]  
On CNET's I'm So Obsessed podcast, director Alex Winter and Frank Zappa's son Ahmet discuss making the documentary Zappa.
9
Director: Aharon OrianProducers: OlamMedia JLMFirst Producer: Chana OrianExecutive Producer: Yoni ZCinematographer: David OrianLine Producer: Mendy CohenAerial Cinematography: Shiran Granot - ElementsDrone Assistant: Joseph BenshimolAerial Hotel: Itamar GreenbergPA: Yosef ArielGaffer: Zusha KaplanBest Boy: Chaim KaplanCamera and Lighting Equipment: Movie MobileWardrobe Design: Uzhasna Couture / Millennial City Art: Chana OrianVintage Cars: Ron & YaronTransportation: Schvartz Trans.See more, Click here
Morgan Stanley just promoted 171 people to managing director - we saw all the names. Plus: bank earnings season, news on SoFi and Roblox.
10
And shortly after Stone stepped down, Margot Robbie was approached for the role.According to Deadline’s recent report, Paramount Pictures delayed the release of the periodic movie by one year.The studio shared that the film will release on 25 December 2022 in limited cinemas and will release on a wide scale on 6 January 2023.The movie was originally scheduled for 2021’s Christmas release.Damien Sayre Chazelle is a director, screenwriter, and producer.He is best known for his movies, including the Academy Award-nominated La La Land, First Man, and Whiplash.And Chazelle’s Babylon is also dealing with such issues, including the shortage of budget.The production of the movie is still on hold due to the lockdown.
The parent company of Warner Bros. has also defended DC Films President Walter Hamada.The statement from the studio has arrived in the aftermath of Ray Fisher’s outrage on Twitter against WarnerMedia and the President of DC films Walter Hamada.And Ray Fisher was kind of expecting this.Anyways, the fact of the matter is that after months of silence and the investigations that happened in between, WarnerMedia has finally come out and defended the most powerful man at the DC Films.Ray Fisher had recently stated that he would never work in a DC film if Walter Hamada stays in his position, and now it seems as if he will remain out of DC films for a while.Even if Fisher has claimed that he will not reprise his role of Cyborg under the current circumstances, he clearly was not happy with the fact that the studio chose to oust him instead of delivering justice.The actor is now renowned for playing the character of Cyborg in the 2017 film “Justice League.”Since last summer, Ray Fisher has been going out all guns blazing against WarnerMedia, the director of the 2017 film “Justice League” Joss Whedon, along with writer Geoff Johns and the President of the DC films Walter Hamada.The most fundamental part of Fisher’s accusation is that all of them created an unprofessional and toxic environment during the filming of the 2017 film Justice League.In response to Fisher’s accusation, WarnerMedia initiated an investigation, which was outsourced to a law firm led by a former federal judge.The studio had hit out against Fisher, calling him very “uncooperative” in the entire matter.As stated earlier, Ray Fisher had firmly stated before that he will not be playing the role of Ray Fisher up until Walter Hamada stays in charge of the DC Films.The statement led many fans to believe that Fisher’s time at DCEU has come to an abrupt end.
HR Acuity, the only technology platform specifically built for employee relations and investigations management, today announced the launch of empowER™, a professional online community created exclusively for employee relations practitioners.It is the first and only expert community serving this market, building upon the reach of the well-established Employee Relations Roundtable community, founded by HR Acuity in 2015.“As employee relations leaders move through the recovery and rebuilding of their organizations this year, community and collaboration have never been more important,” said Deborah J. Muller, Founder and CEO of HR Acuity.“The employee relations community came together in 2020, sharing knowledge to help one another lead their teams through the pandemic, manage workplace activism and forge new paths for diversity, equity and inclusion.We are proud to launch empowER to formalize that collaboration and offer expertise to employee relations leaders everywhere.”The empowER community was inspired by the HR Acuity Employee Relations Roundtable, a one-of-a-kind forum that brings together senior employee relations leaders from organizations like Adobe, Google, LinkedIn, Nike, TIAA, Qualcomm, Workday and Verizon to connect, interact and share practices, processes and experiences related to employee relations and the employee experience.Created in response to requests from Roundtable members, the empowER community is designed for ongoing discussion and peer connection to help navigate the changing employee relations and workplace environment.With 79% of respondents from HR Acuity’s Fourth Annual Benchmark Study saying a dedicated online space for ER professionals would make their jobs easier, the empowER online community will offer thought leadership, connection and collaboration to a broader audience.All employee relations professionals can request to join the site, which includes:Collaboration and community – Discussion and updates in a social media style formatER-specific resources – Expert practices, playbooks, webinars, videos and news for managing employee relations issues, including COVID-19 resourcesEvents – Webinars and virtual events targeted at the employee relations communityJobs – Members can post and apply for ER-specific roles“The HR Acuity Employee Relations Roundtable community is an unmatched resource for innovative thinking, insights, best practices and peer connections,” said Michele Sommer, Senior Vice President, Director Employee Relations, Citizens Bank.“With empowER, I am excited to have real-time access to other employee relations thought leaders to help us continue to build a strategic ER function.”For more such Updates Log on to www.hrtechcube.com
Phenom, the global leader in Talent Experience Management (TXM), today announced its partnership with Parisima, a leading strategic talent advisory and delivery business based in Dubai.With Parisima’s expertise in the TXM platform and esteemed reputation in the Middle East, HR teams will be able to rapidly deploy powerful automation intelligence and increase their overall efficiency.The digital transformation of HR infrastructure in the region has accelerated since the start of 2020, but a recent survey of local HR professionals revealed only 9% think their organization is innovating talent management with technology*.In addition to enhancing the hiring process, Phenom and Parisima empower enterprises to create greater flexibility through upskilling.Team leaders can leverage the TXM platform to identify emerging skills among employees and recommend internal projects where those skills can grow.“We are excited to introduce companies in the region to Phenom and their holistic, AI-based technology,” said Tim Taylor, managing director and partner at Parisima.“Amid current market conditions, businesses are facing many new challenges for which they need agile, innovative talent experience solutions.Our strategic alliance with Phenom will help our clients across the whole talent lifecycle.
More

Top